EIP
CURE icon

Ellis Investment Partners’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Ellis Investment Partners’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-202
Closed -$17K – 306
2022
Q3 		$17K Buy
202
+1
+0.5% +$103 ﹤0.01% 503
2022
Q2 		$20K Hold
201
– – 0.01% 501
2022
Q1 		$26K Sell
201
-200
-50% -$23.8K 0.01% 490
2021
Q4 		$58K Hold
401
– – 0.01% 398
2021
Q3 		$43K Hold
401
– – 0.01% 416
2021
Q2 		$41K Hold
401
– – 0.01% 423
2021
Q1 		$34K Sell
401
-100
-20% -$8.06K 0.01% 436
2020
Q4 		$39K Buy
501
+100
+25% +$6.88K 0.01% 408
2020
Q3 		$25K Sell
401
-1,664
-81% -$104K 0.01% 445
2020
Q2 		$114K Buy
2,065
+600
+41% +$31.8K 0.04% 243
2020
Q1 		$51K Buy
1,465
+302
+26% +$19K 0.02% 293
2019
Q4 		$86K Sell
1,163
-1,325
-53% -$81K 0.03% 255
2019
Q3 		$122K Buy
2,488
+1,368
+122% +$72.6K 0.04% 203
2019
Q2 		$63K Buy
+1,120
New +$57.8K 0.02% 301

Other funds holding CURE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
C
Covestor London, United Kingdom $144M AUM 37.32% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Ellis Investment Partners's CURE Position: Q4 2022 in Review

Ellis Investment Partners sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q4 2022, closing a stake of 202 shares — an estimated $17K sold.

Ellis Investment Partners first reported a position in CURE in Q2 2019 and held it in 14 quarters. The position peaked at $122K in Q3 2019. 20 funds tracked by Wall St. Rank hold CURE as of Q4 2022.

  • Ellis Investment Partners reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 202 Direxion Daily Healthcare Bull 3X ETF shares in Q4 2022, an estimated $17K.
  • Ellis Investment Partners first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q2 2019 and held it in 14 quarters.
  • Ellis Investment Partners's Direxion Daily Healthcare Bull 3X ETF position peaked at $122K in Q3 2019.
  • 20 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.